Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism Kei ZaitsuMunehiro KatagiAkira Ishii Review Article 10 December 2013 Pages: 1 - 8
Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products Nahoko UchiyamaSatoru MatsudaYukihiro Goda Original Article 23 June 2013 Pages: 9 - 18
Development of ultrasound-assisted dispersive liquid–liquid microextraction–large volume injection–gas chromatography–tandem mass spectrometry method for determination of pyrethroid metabolites in brain of cypermethrin-treated rats Mohana Krishna Reddy MudiamRajeev JainDevendra Parmar Original Article 24 July 2013 Pages: 19 - 29
Simultaneous and sensitive analysis of fourth-generation antidepressants in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry Kenya IwakuraTadashi OgawaTakashi Nakagawa Original Article 09 July 2013 Pages: 30 - 38
Presence of appreciable amounts of ethylene glycol, propylene glycol, and diethylene glycol in human urine of healthy subjects Amin WuritaOsamu SuzukiKanako Watanabe Original Article 17 August 2013 Pages: 39 - 44
Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product Nozomi UemuraHaruhiko FukayaDai Nakae Original Article 17 August 2013 Pages: 45 - 50
Analysis of 11-nor-9-carbonyl-∆9-tetrahydrocannabinol in human blood and bile by liquid chromatography–tandem mass spectrometry after derivatization with ethyl chloroformate and amines Koji YamaguchiMakiko HayashidaYoukichi Ohno Original Article 27 July 2013 Pages: 51 - 58
Metabolism of the newly encountered designer drug α-pyrrolidinovalerophenone in humans: identification and quantitation of urinary metabolites Noriaki ShimaMunehiro KatagiKoichi Suzuki Original Article 13 August 2013 Pages: 59 - 67
Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human Akira NameraKyohei KonumaMasataka Nagao Original Article 11 August 2013 Pages: 68 - 74
An LC–MS–MS method for quantitation of four new phenethylamines (BOX series) in plasma: in vivo application Gianpiero BoattoMaria Antonietta PirisiMaria Nieddu Original Article 10 August 2013 Pages: 75 - 81
Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013 Heesun ChungHyeyoung ChoiJaesin Lee Original Article 26 October 2013 Pages: 82 - 88
A simple method for the simultaneous determination of mushroom toxins by liquid chromatography–time-of-flight mass spectrometry Naoki YoshiokaShigeki AkamatsuYasuhiro Ueno Original Article 20 November 2013 Pages: 89 - 96
Rapid and simultaneous extraction of acidic and basic drugs from human whole blood for reliable semi-quantitative NAGINATA drug screening by GC–MS Keiko KudoYosuke UsumotoNoriaki Ikeda Original Article 26 November 2013 Pages: 97 - 104
Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products Nahoko UchiyamaYoshihiko ShimokawaYukihiro Goda Original Article 26 November 2013 Pages: 105 - 115
Erratum to: Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products Nahoko UchiyamaYoshihiko ShimokawaYukihiro Goda Erratum 11 December 2013 Pages: 116 - 117
Fentanyl: cause of death or incidental finding? Postmortem peripheral blood concentrations with and without documented transdermal patch use Derrick D. LungNikolas P. Lemos Original Article 29 November 2013 Pages: 118 - 125
High-throughput analysis of ramelteon, agomelatine, and melatonin in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry Tadashi OgawaMasae IwaiHiroshi Seno Short Communication 26 June 2013 Pages: 126 - 131
Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests Maria NiedduLucia BurraiGianpiero Boatto Short Communication 20 July 2013 Pages: 132 - 138
Application of modified QuEChERS method to liver samples for forensic toxicological analysis Kiyotaka UsuiMasaki HashiyadaMasato Funayama Short Communication 28 August 2013 Pages: 139 - 147
Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet Jaesin LeeBastiaan J. VenhuisEunmi Kim Short Communication 20 August 2013 Pages: 148 - 153
Simultaneous determination of tryptamine analogues in designer drugs using gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry Yukiko NakazonoKenji TsujikawaHiroyuki Inoue Short Communication 11 September 2013 Pages: 154 - 161
Occurrence of postmortem production of ethylene glycol and propylene glycol in human specimens Amin WuritaOsamu SuzukiKanako Watanabe Short Communication 11 October 2013 Pages: 162 - 168
MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood Kayoko MinakataItaru YamagishiOsamu Suzuki Short Communication 19 October 2013 Pages: 169 - 175
Interpretation of a highly positive ethyl glucuronide result together with negative fatty acid ethyl esters result in hair and negative blood results Pascal KintzDavid Nicholson Case Report 05 October 2013 Pages: 176 - 179
Homicide–suicide by oral administration of cyclobarbital Suguru TorimitsuDaisuke YajimaHirotaro Iwase Case Report 24 October 2013 Pages: 180 - 185
A large proportion of intravenously administered methamphetamine is excreted into the stomach Fumio MoriyaKei YoshitomeSatoru Miyaishi Letter to the Editor 14 August 2013 Pages: 186 - 188